While no human trials have tested vitamin D’s direct effect on CeD pathology, animal models show that high-dose cholecalciferol ameliorates villus atrophy, reduces CD3+ infiltration, and restores ZO-1 expression [8]. This evidence concerns the gene TJP1 and cranioectodermal dysplasia.